Sernova Corp.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Sernova Corp. is a clinical-stage regenerative medicine company developing the Cell Pouch System™ to treat patients with chronic metabolic, hematological and neurological diseases with first therapeutic applications in diabetes, hemophilia A and thyroid disease.

Sernova's Cell Pouch ™ is a novel, proprietary, scalable, implantable macro-encapsulation device designed for the long- term survival and function of therapeutic cells. The device is designed to incorporate with tissue, forming highly vascularized tissue chambers for the transplantation and function of therapeutic cells which then release proteins and hormones as required to treat disease. The device along with therapeutic cells has been shown to provide long-term safety and efficacy in small and large animal models of diabetes and has been proven to provide a biologically compatible environment for insulin-producing cells in humans.
Ticker:
SVA - SEOVF
Exchange:
TSX-V - OTCQB
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Ontario
Company HQ Country:
Canada
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Cell Pouch System
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
President and CEO
Sernova Corp.